Skip to content
★ Sign in to follow
Total declarations
70
Companies
5
▲ Purchases (4 ops.)
€277k
▼ Sales (22 ops.)
€5.9M

Latest filing published 13 Jan 2017 for General Mills INC, €549k.

Filing timeline

BuySale
Robert L. Ryan

Insider track record

Disclosed buys
4
Disclosed sells
22
Signal history

Closed purchases

Market purchases
4
Positive at T+90
50%
Median T+90
-13.9%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 28 May 2009 · 6373 days ago · €55k
    +26.6%
    Entry US$16.35 · Close at T+365 US$20.70
  • Filed 17 Nov 2008 · 6565 days ago · €88k
    -33.4%
    Entry US$64.00 · Close at T+365 US$42.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert L. Ryan: trading record in brief

Robert L. Ryan discloses dealings in 5 companies, chiefly Unitedhealth Group Inc, General Mills Inc and Citigroup Inc. We count 70 filings; the first trade dates from 14 March 2006 and the latest from 11 January 2017.

Market trades split into 4 purchases (€277k) and 22 sales (€5.9M). Netting one side against the other leaves €5.6M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 23 share grants and 17 option exercises. So far in 2017, the count stands at no purchases and 1 sale.

A typical purchase (the median) is worth €71k. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was -13.9%. Past outcomes like these are no guarantee of what comes next.

The newest entry dates from 13 January 2017: an option exercise of €549k, in General Mills Inc. The latest purchase dates back some time: it was published 6,373 days ago, on 28 May 2009. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert L. Ryan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations68 total

25 of 68 declarations